Navigation Links
St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse
Date:11/27/2008

lapse pathways will lead to understanding of the biological machinery of relapse, and ultimately to drugs that target that machinery. Such studies of the relapse machinery are now underway at St. Jude.

In other further studies, the researchers are also looking for other relapse-related genetic alterations besides copy number abnormalities. They are also applying their findings to adult ALL, in which relapse is a more significant problem than in the childhood disease.

Other authors of this paper include Letha Phillips, Xiaoping Su, Jing Ma, Christopher Miller and Sheila Shurtleff.

The research was supported in part by the National Health and Medical Research Council of Australia and ALSAC.

St. Jude Children's ResearchHospital

St. Jude Children's Research Hospital is internationally recognized for its pioneering work in finding cures and saving children with cancer and other catastrophic diseases. Founded by late entertainer Danny Thomas and based in Memphis, Tenn., St. Jude freely shares its discoveries with scientific and medical communities around the world. No family ever pays for treatments not covered by insurance, and families without insurance are never asked to pay. St. Jude is financially supported by ALSAC, its fundraising organization. For more information, please visit www.stjude.org.


'/>"/>
SOURCE St. Jude Children's Research Hospital
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. St. Jude Identifies the Specific Cell That Causes Eye Cancer, Disproving Long-Held Theory
2. New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
3. Research Identifies Need for Improved Understanding of Sickle Cell Disease in Adulthood
4. Steps Toward Stopping Autoimmune Disease: International Consortium Identifies Genes Linked to Lupus
5. Joslin Study Identifies Key Factor That Links Metabolic Syndrome; Finding May Help Millions at High Risk of Cardiovascular Disease
6. JACC Identifies DEFER with 5-year Outcomes as Landmark Trial
7. Mayo Clinic Study Identifies Potential Causes of Young-Onset Dementia
8. SuperGen Identifies Lead PIM Kinase Inhibitor, SGI-1776, That Causes Tumor Regression in AML Xenograft Models
9. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
10. Nemours Center for Childhood Cancer Research Team at the Alfred I. duPont Hospital for Children Identifies the Function of a Biomarker Present in Prostate Cancer Cells: New Insight into Therapeutic Benefit for Patients with Advanced Prostate Cancer
11. Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., Ill., Dec. 2 Abbott,s ... vast array of microorganisms has been named one o...agazine. A panel of expert judges evaluated a bro... the year,s top innovations, with the winners unve...e at www.the-scien t ist.com/top10innovations ...
(Date:12/2/2009)...ALLS, N.J., Dec. 2 Cante...sults for its first quarter ended October 31, 2009... conference call to discuss the results at 11:00 A.... Diker, Chairman; Andrew A. Krakauer, President a...raig A. Sheldon, Senior Vice President, CFO and Tr...
(Date:12/2/2009)..., Dec. 2 Laser Spine Institute (...ery, is pleased to announce a partnership with Un... six-month negotiation and clinical review process...provider of minimally invasive spinal surgery to e...ediately, patients with United Healthcare may be c...
Breaking Medicine Technology:Abbott's Ibis Technology Named One of the Top Innovations for 2009 by The Scientist 2Cantel Medical Corp. to Hold Conference Call to Discuss Results for its First Quarter Ended October 31, 2009 2Laser Spine Institute Partners with United Healthcare 2Laser Spine Institute Partners with United Healthcare 3Mobile MedCheck Brings Back House Calls 54959 1Mobile MedCheck Brings Back House Calls 54959 2Mobile MedCheck Brings Back House Calls 54959 3Mobile MedCheck Brings Back House Calls 54959 4Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 1Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 2Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 3Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 4Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 5Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 1Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 2Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 3
... The Michael J. Fox,Foundation for Parkinson,s Res...ch teams to speed development of effective therapi...ted symptoms of Parkinson,s disease.,Patients ofte... with,executive function (the ability to formulate...sion, apathy and anxiety; and behavioral issues,in...
...IRIT II and SPIRIT III Data Confirms Patients Trea...ng Death, a Heart Attack or a Repeat Pro...TON, Oct. 13 Data from an independent,meta-analys... clinical,trials demonstrated that the XIENCE V(TM...es to deliver clinically significant benefits for ...
Other Medicine Technology:Michael J. Fox Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinson's Disease 2Michael J. Fox Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinson's Disease 3Michael J. Fox Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinson's Disease 4Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 2Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 3Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 4Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 5
(Date:12/2/2009)... -- Reportlinker.com announces that a new market r..., Antibiotic Resistance and Antibiotic Technologi....com/p0166825/Antibiotic-Resistance-and-Antibiotic...n in-depth review of the global market for antibio... Offer an analysis of antibiotics resistance from ...
(Date:12/2/2009)...e/ -- The Washington Post reported that Cyber Mond...rics, a marketing optimization company, internet s... Cyber Monday 2008. ,, Contrast those statistic...today "Cyber Monday website traffic rose 76% and C...y Amorosino, COO of Bella Sante. ,, Why is Be...
(Date:12/2/2009)...ounter recent increases in longevity , ,... health of the U.S. population has improved over t... quit smoking in droves, but a new study suggests ...obesity rates among Americans don,t level off or d...esity continue unchanged, the average life expecta...
(Date:12/2/2009)..., researchers say , , WEDNESDAY, Dec. 2 ...yme replacement therapy can make a major differenc...e illness that affects the kidneys, heart and brai...ck of an enzyme that helps metabolic pathways func...he risk for a stroke, heart attack and kidney dise...
(Date:12/2/2009)...swire/ -- By now, most people have heard of the e-...grow in popularity. And, the latest product on the...- the new single piece PremiumOne(TM) disposable e...f $14.99. ,, "This new product makes it possibl...price, before making a bigger investment in a smok...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 2Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 3Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 4Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 5Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 6Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 7Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 8Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 9Health News:The Washington Post Reported That Cyber Monday Website Traffic Rises 8%. Boston's Bella Sante Day Spas Cyber Monday Website Traffic Rises 76%. 2Health News:The Washington Post Reported That Cyber Monday Website Traffic Rises 8%. Boston's Bella Sante Day Spas Cyber Monday Website Traffic Rises 76%. 3Health News:Health Gains From Lowered Smoking Rates in Jeopardy 2Health News:Health Gains From Lowered Smoking Rates in Jeopardy 3Health News:A Smokeless Holiday Season? Premium Electronic Cigarette Announces New Disposable Smokeless Cigarette Product 2
... March 24 Eastern Michigan University School ...Michigan departments of Energy, Labor & Econom..., Awarded as part of the Michigan Nurse Corps (MNC... study. , , The MNC provides educational stipends...
...anization facilitates blood transfusion services f..., SEATTLE, March 24 NetMotion Wireless, a leading...ftware, announced today that its Mobile Virtual Pr...cations as they move across Washington State, serv...
..., March 24 In a letter to the Centers for Medicar...ader John Boehner (R-OH) urged CMS to reconsider p...services, supplies, and other obligations after 36... , , Citing lack of payments for maintenance and ...
...21st Annual American Diabetes Alert Day , , HAR... to rise, Department of Health Secretary Everette ...o learn about steps they can take to prevent or de...le in its development," said Secretary James. "Tak...
...yme deficiency would save many lives, study sugges...-- People who experience facial flushing when they...ohol-related esophageal cancer, say American and J...d Koreans), mainly due to an inherited deficiency ...
...r investment in research to stem ,crippling, expen... -- In a new report, the Alzheimer,s Association e...ple the health-care costs for afflicted seniors. ,...ound. The association also estimates that nearly 1...
Other Medicine News:Health News:EMU Receives $634,000 Grant From State to Help Stem Nursing Shortage 2Health News:NetMotion Wireless Boosts Mobile Productivity for Puget Sound Blood Center 2Health News:NetMotion Wireless Boosts Mobile Productivity for Puget Sound Blood Center 3Health News:NetMotion Wireless Boosts Mobile Productivity for Puget Sound Blood Center 4Health News:House Republican Leader Boehner Says CMS Policies on Home Oxygen Therapy Will 'Potentially Harm' Care Available to Medicare Beneficiaries 2Health News:Control or Prevent Diabetes Through Healthier Habits, Pennsylvania Health Secretary Urges 2Health News:Flushing From Alcohol a Risk Factor for Esophageal Cancer 2Health News:With Alzheimer's, Health-Care Costs Could Triple 2
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
Medicine Products: